Adaptimmune Therapeutics PLC Files 8-K
| Field | Detail |
|---|---|
| Company | Adaptimmune Therapeutics PLC |
| Form Type | 8-K |
| Filed Date | Mar 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, sec-filing
Related Tickers: ADAP
TL;DR
Adaptimmune dropped an 8-K on 3/20/25 covering financials and operations.
AI Summary
Adaptimmune Therapeutics PLC filed an 8-K on March 20, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosures and financial statements and exhibits. The company is incorporated in England and Wales and is involved in the biological products sector.
Why It Matters
This 8-K filing provides crucial updates on Adaptimmune's financial performance and operational status, which is essential for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for financial and operational updates, not indicating any immediate or significant new risks.
Key Players & Entities
- Adaptimmune Therapeutics PLC (company) — Registrant
- March 20, 2025 (date) — Date of earliest event reported
- England and Wales (jurisdiction) — State or other jurisdiction of incorporation
- 60 Jubilee Avenue, Milton Park Abingdon, Oxfordshire OX14 4RX United Kingdom (address) — Address of principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Adaptimmune Therapeutics PLC's results of operations and financial condition, along with Regulation FD disclosures and financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 20, 2025.
Where is Adaptimmune Therapeutics PLC incorporated?
Adaptimmune Therapeutics PLC is incorporated in England and Wales.
What is the principal executive office address for Adaptimmune Therapeutics PLC?
The principal executive office address is 60 Jubilee Avenue, Milton Park Abingdon, Oxfordshire OX14 4RX, United Kingdom.
What is the SIC code for Adaptimmune Therapeutics PLC?
The Standard Industrial Classification (SIC) code for Adaptimmune Therapeutics PLC is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 20, 2025 regarding Adaptimmune Therapeutics PLC.